Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024
01 Mai 2024 - 1:00PM
Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company
will host a conference call and live audio webcast on Thursday, May
9, 2024, at 8:30 a.m. ET to discuss financial results for the first
quarter ended March 31, 2024.
Participants and investors interested in
accessing the call by phone will need to register using the online
registration form. After registering, all phone participants will
receive a dial-in number along with a personal PIN to access the
event. A live audio webcast and related presentation materials can
also be accessed via the Investors section of the Amicus
Therapeutics corporate website at ir.amicusrx.com. Web participants
are encouraged to register on the website 15 minutes prior to the
start of the call.
An archived webcast and accompanying slides will
be available on the Company's website shortly after the conclusion
of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
diseases. With extraordinary patient focus, Amicus Therapeutics is
committed to advancing and expanding a pipeline of cutting-edge,
first- or best-in-class medicines for rare diseases. For more
information please visit the company’s website at www.amicusrx.com,
and follow on Twitter and LinkedIn.
CONTACT:
Investors:Amicus
TherapeuticsAndrew FaughnanVice President, Investor
Relationsafaughnan@amicusrx.com (609) 662-3809
Media:Amicus TherapeuticsDiana
MooreHead of Global Corporate Affairs &
Communicationsdmoore@amicusrx.com (609) 662-5079
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Amicus Therapeutics (NASDAQ:FOLD)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024